Search results
FDA panel votes against MDMA for PTSD, setting up hurdle to approval
CBS News· 12 hours agoPotential approval of MDMA to treat post-traumatic stress disorder hit a major hurdle Tuesday, as a...
FDA advisers vote against recommending approval of MDMA as treatment for PTSD
ABC News· 12 hours agoA panel of independent advisers for the U.S. Food and Drug Administration voted against recommending...
FDA panel rejects MDMA-based treatment for PTSD
The Hill· 7 hours agoThe Food and Drug Administration (FDA) panel voted 10-1 against endorsing the safety of MDMA in treating PTSD, and 9-2 against its efficacy. The FDA is...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 18 hours agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
WUSF 89.7· 8 hours agoIt represents a major setback for proponents of the drug and its sponsor Lykos Therapeutics,...
FDA advisers vote against first MDMA therapy to treat PTSD
CNN via AOL· 11 hours agoA federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly...
FDA warns parents about Crecelac infant formula—what parents need to know about the recall
Motherly via Yahoo News· 22 hours agoCompanies that distribute infant formula in the U.S. are required to submit data to the FDA that...
FDA Panel Rejects MDMA Therapy For PTSD, Citing Concerns Over Research Data In Setback For Advocates
Benzinga· 8 hours agoMDMA, also known as ecstasy, has been studied for over a decade as a potential treatment for mental...
FDA panel votes against MDMA therapy for PTSD, citing muddy data and safety concerns
BioPharma Dive via Yahoo Finance· 16 hours agoA group of independent experts wasn't convinced by clinical trial data from company Lykos...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
NBC NEWS· 12 hours agoA Food and Drug Administration advisory panel on Tuesday declined to recommend the approval of MDMA...